Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study

BACKGROUND: Serum albumin may be used to stratify human immunodeficiency virus (HIV)–infected persons with high CD4 count according to their risk of serious non-AIDS endpoints. METHODS: Cox proportional hazards models were used to analyze the risk of serious non-AIDS events in the Strategic Timing o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Ronit, Andreas, Sharma, Shweta, Baker, Jason V, Mngqibisa, Rosie, Delory, Tristan, Caldeira, Luis, Ndembi, Nicaise, Lundgren, Jens D, Phillips, Andrew N
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5853310/
https://ncbi.nlm.nih.gov/pubmed/29244111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix350
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados